Skip to product information
1 of 1

KAMA 4ct Psuedoindoxyl Tabs Grape 50mg per Tablet

KAMA 4ct Psuedoindoxyl Tabs Grape 50mg per Tablet

Regular price $24.95 USD
Regular price Sale price $24.95 USD

$6.24 per Tab

$0.12 per Mg

Sale Sold out
Taxes included. Shipping calculated at checkout.

Earn [points_amount] when you buy this item.

Secured checkout with

  • American Express
  • Diners Club
  • Discover
  • JCB
  • Mastercard
  • Visa
  • Quality & Value

    Best Competitive Pricing Anywhere

  • Fast Fulfillment

    We Pack In Hours Mon thru Sat

  • Safe Payment

    Secure Checkout with Visa/MC

View full details

KAMA Pseudoindoxyl Tablets (Grape) – 50mg Standardized Chewables (4 Count Pack)

KAMA Pseudoindoxyl Tablets provide a standardized 50mg pseudoindoxyl portion per chewable, packaged in a compact 4-count blister (200mg total). This format is built for experienced adult users who value precision, portability, and transparent quality over guesswork. Instead of handling variable plain leaf material or bulkier delivery forms, you get a focused, pre-measured chewable tablet that supports consistent personal planning without scoops, shaking, or messy preparation. Each tablet features a balanced concord-style grape flavor that softens natural alkaloid bitterness while avoiding excessive sweetness, making it discreet for travel, a pocket, or a desk drawer.

The core differentiator is standardization: a kratom-derived pseudoindoxyl extract refined and portioned so each unit delivers a repeatable 50mg amount. That reliability streamlines routines for users who prefer concentrated profiles versus larger-volume botanical material. Third-party laboratory testing underpins each batch—identity confirmation, potency verification, and contaminant screening (heavy metals, microbial, common adulterants)—so you can reference a batch Certificate of Analysis where provided. This emphasis on lab transparency supports informed, responsible use rather than hype or unverified claims.

The formulation is deliberately concise: active pseudoindoxyl extract, a grape flavor system for palatability, sweetening and plant-based binders for structural integrity, plus inert excipients that aid uniform compression and chew. It is non-GMO and gluten-free. By minimizing unnecessary fillers, the tablet preserves a small footprint that slips easily into daily carry kits while helping reduce dosing variability. Users who have migrated from broader-spectrum, unstandardized material often appreciate the clarity that a defined milligram amount brings to personal planning and inventory tracking.

Because potency is concentrated, a conservative mindset remains important. Many experienced users choose to begin with half a tablet when first evaluating a new standardized format, allowing a full personal evaluation window before considering any additional intake. Chew thoroughly rather than swallowing whole. Individual factors—recent meals, hydration status, metabolic variability—can influence perceived timing, so patience helps avoid stacking portions too quickly. Avoid combining with alcohol, sedatives, opioids, or other central nervous system depressants. Do not drive or operate machinery if you feel impaired. This product is intended strictly for responsible adult users; it is not for minors, and those who are pregnant, nursing, or managing health conditions should refrain unless advised by a qualified professional.

Proper storage supports longevity and integrity: keep the blister sealed until use; store in a cool, dry location away from direct heat, light, and moisture; and keep out of reach of children and pets. The durable blister format helps shield tablets from incidental humidity and abrasion during transport while providing visual confirmation of unit integrity. By uniting standardized pseudoindoxyl potency, discrete form factor, lab-backed verification, and a palatable grape profile, KAMA Pseudoindoxyl Tablets serve users seeking a precise, portable, and streamlined option. Use only as directed and in compliance with applicable laws. Statements have not been evaluated by the Food and Drug Administration; this product is not intended to diagnose, treat, cure, or prevent any disease.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)